Literature DB >> 21187402

Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer.

Yoku Hayakawa1, Yoshihiro Hirata, Hayato Nakagawa, Kei Sakamoto, Yohko Hikiba, Hiroto Kinoshita, Wachiko Nakata, Ryota Takahashi, Keisuke Tateishi, Motohisa Tada, Masao Akanuma, Haruhiko Yoshida, Kohsuke Takeda, Hidenori Ichijo, Masao Omata, Shin Maeda, Kazuhiko Koike.   

Abstract

Mitogen-activated protein kinase (MAPK) pathways regulate multiple cellular functions and are highly active in many types of human cancers. Apoptosis signal-regulating kinase 1 (ASK1) is an upstream MAPK involved in apoptosis, inflammation, and carcinogenesis. This study investigated the role of ASK1 in the development of gastric cancer. In human gastric cancer specimens, we observed increased ASK1 expression, compared to nontumor epithelium. Using a chemically induced murine gastric tumorigenesis model, we observed increased tumor ASK1 expression, and ASK1 knockout mice had both fewer and smaller tumors than wild-type (WT) mice. ASK1 siRNA inhibited cell proliferation through the accumulation of cells in G1 phase of the cell cycle, and reduced cyclin D1 expression in gastric cancer cells, whereas these effects were uncommon in other cancer cells. ASK1 overexpression induced the transcription of cyclin D1, through AP-1 activation, and ASK1 levels were regulated by cyclin D1, via the Rb-E2F pathway. Exogenous ASK1 induced cyclin D1 expression, followed by elevated expression of endogenous ASK1. These results indicate an autoregulatory mechanism of ASK1 in the development of gastric cancer. Targeting this positive feedback loop, ASK1 may present a potential therapeutic target for the treatment of advanced gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21187402      PMCID: PMC3021038          DOI: 10.1073/pnas.1011418108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation.

Authors:  E S Knudsen; J Y Wang
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

2.  Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.

Authors:  A S Lundberg; R A Weinberg
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

3.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.

Authors:  M Saitoh; H Nishitoh; M Fujii; K Takeda; K Tobiume; Y Sawada; M Kawabata; K Miyazono; H Ichijo
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

4.  Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach.

Authors:  N Arber; M D Gammon; H Hibshoosh; J A Britton; Y Zhang; J B Schonberg; H Roterdam; I Fabian; P R Holt; I B Weinstein
Journal:  Hum Pathol       Date:  1999-09       Impact factor: 3.466

5.  Gastric cancer originating from bone marrow-derived cells.

Authors:  Jeanmarie Houghton; Calin Stoicov; Sachiyo Nomura; Arlin B Rogers; Jane Carlson; Hanchen Li; Xun Cai; James G Fox; James R Goldenring; Timothy C Wang
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

6.  Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways.

Authors:  H Ichijo; E Nishida; K Irie; P ten Dijke; M Saitoh; T Moriguchi; M Takagi; K Matsumoto; K Miyazono; Y Gotoh
Journal:  Science       Date:  1997-01-03       Impact factor: 47.728

7.  The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach.

Authors:  H Nakagawa; T C Wang; L Zukerberg; R Odze; K Togawa; G H May; J Wilson; A K Rustgi
Journal:  Oncogene       Date:  1997-03-13       Impact factor: 9.867

Review 8.  Cancer cell cycles.

Authors:  C J Sherr
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

Review 9.  Recent discoveries in cancer genetics of exocrine pancreatic neoplasia.

Authors:  S A Hahn; W H Schmiegel
Journal:  Digestion       Date:  1998-08       Impact factor: 3.216

10.  ASK1 is essential for JNK/SAPK activation by TRAF2.

Authors:  H Nishitoh; M Saitoh; Y Mochida; K Takeda; H Nakano; M Rothe; K Miyazono; H Ichijo
Journal:  Mol Cell       Date:  1998-09       Impact factor: 17.970

View more
  48 in total

1.  Role of apoptosis signal-regulating kinase 1 (ASK1) as an activator of the GAPDH-Siah1 stress-signaling cascade.

Authors:  Carlos A Tristan; Adriana Ramos; Neelam Shahani; Francesco E Emiliani; Hidemitsu Nakajima; Christopher C Noeh; Yoshinori Kato; Tadayoshi Takeuchi; Takuya Noguchi; Hisae Kadowaki; Thomas W Sedlak; Koko Ishizuka; Hidenori Ichijo; Akira Sawa
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

2.  Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function.

Authors:  James I Macdonald; Frederick A Dick
Journal:  Genes Cancer       Date:  2012-11

3.  Cyclin D1b overexpression inhibits cell proliferation and induces cell apoptosis in cervical cancer cells in vitro and in vivo.

Authors:  Ning Wang; Heng Wei; Duo Yin; Yanming Lu; Yao Zhang; Di Jiang; Yan Jiang; Shulan Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 4.  The role of noncoding RNA in hepatocellular carcinoma.

Authors:  Zhuolu Wang; Xinying Li
Journal:  Gland Surg       Date:  2013-02

Review 5.  Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.

Authors:  Samuel Lee; Soo Min Kim; Richard T Lee
Journal:  Antioxid Redox Signal       Date:  2012-06-26       Impact factor: 8.401

6.  Large tumor suppressor 2, LATS2, activates JNK in a kinase-independent mechanism through ASK1.

Authors:  Lauren Rusnak; Cong Tang; Qi Qi; Xiulei Mo; Haian Fu
Journal:  J Mol Cell Biol       Date:  2018-12-01       Impact factor: 6.216

7.  The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis.

Authors:  Peng Zhang; Pi-Xiao Wang; Ling-Ping Zhao; Xin Zhang; Yan-Xiao Ji; Xiao-Jing Zhang; Chun Fang; Yue-Xin Lu; Xia Yang; Mao-Mao Gao; Yan Zhang; Song Tian; Xue-Yong Zhu; Jun Gong; Xin-Liang Ma; Feng Li; Zhihua Wang; Zan Huang; Zhi-Gang She; Hongliang Li
Journal:  Nat Med       Date:  2017-12-11       Impact factor: 53.440

8.  Structural basis of autoregulatory scaffolding by apoptosis signal-regulating kinase 1.

Authors:  Johannes F Weijman; Abhishek Kumar; Sam A Jamieson; Chontelle M King; Tom T Caradoc-Davies; Elizabeth C Ledgerwood; James M Murphy; Peter D Mace
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-27       Impact factor: 11.205

9.  Therapeutic effect of c-Jun N-terminal kinase inhibition on pancreatic cancer.

Authors:  Ryota Takahashi; Yoshihiro Hirata; Kosuke Sakitani; Wachiko Nakata; Hiroto Kinoshita; Yoku Hayakawa; Hayato Nakagawa; Kei Sakamoto; Yohko Hikiba; Hideaki Ijichi; Harold L Moses; Shin Maeda; Kazuhiko Koike
Journal:  Cancer Sci       Date:  2013-01-24       Impact factor: 6.716

10.  Peroxiredoxin 1 suppresses apoptosis via regulation of the apoptosis signal-regulating kinase 1 signaling pathway in human oral leukoplakia.

Authors:  Min Zhang; Wenwen Niu; Jianfei Zhang; Lihua Ge; Jing Yang; Zheng Sun; Xiaofei Tang
Journal:  Oncol Lett       Date:  2015-06-25       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.